Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Altamira Therapeutics Announces Publication Of Results From Bentrio Trial In Seasonal Allergic Rhinitis In Peer Reviewed Journal

Author: Benzinga Newsdesk | April 24, 2024 08:48am
  • Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal
  • Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013)
  • Corroborated by statistically significant improvement in health-related quality of life and reduced need for relief medication
  • Study outcomes support plans for further international expansion

Posted In: CYTO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist